ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
8.16
+0.01 (0.12%)
Oct 19, 2026, 1:13 PM EDT - Market open
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $73.18 million as of October 19, 2026. It is the 27,518th most valuable company in the world and the 4,362nd biggest in the United States. Its market cap has increased by 220.95% in one year.
Market Cap
73.18M
Enterprise Value
19.71M
1-Year Change
220.95%
Global Rank
Country Rank
#4,362 United States
Category
ChartMarket Cap Chart
Since July 8, 2022, ProMIS Neurosciences's market cap has increased from $66.60M to $73.18M, an increase of 9.87%. That is a compound annual growth rate of 2.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 73.18M | 397.80% |
| Dec 31, 2025 | 14.70M | -52.58% |
| Dec 31, 2024 | 31.00M | 42.86% |
| Dec 29, 2023 | 21.70M | -41.67% |
| Dec 30, 2022 | 37.20M | -44.14% |
| Jul 8, 2022 | 66.60M | - |
View and export this data all the way back to 2022. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 79.05M |
| Telomir Pharmaceuticals | 78.68M |
| Pelthos Therapeutics | 77.18M |
| Nutriband | 77.07M |
| Equillium | 76.72M |
| OKYO Pharma | 74.00M |
| Cardiff Oncology | 72.39M |
| Acrivon Therapeutics | 71.57M |